Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of Barzolvolimab in Patients With Prurigo Nodularis

ClinicalTrials.gov ID: NCT06366750

Public ClinicalTrials.gov record NCT06366750. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Patients With Prurigo Nodularis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.

Study identification

NCT ID
NCT06366750
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celldex Therapeutics
Industry
Enrollment
140 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 12, 2024 (Actual)
Primary completion
Mar 17, 2026 (Actual)
Completion
Mar 2027 (Estimated)
Last update posted
Aug 4, 2026

2024 – 2027

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Total Dermatology Birmingham Alabama 35203 —
Cahaba Dermatology Skin Health Center Birmingham Alabama 35244 —
Investigate MD, LLC Scottsdale Arizona 85255 —
Scottsdale Clinical Trials Scottsdale Arizona 85260 —
Center for Dermatology Clinical Research, Inc Fremont California 94538 —
Profound Research LLC Oceanside California 92056 —
Empire Clinical Research Pomona California 91767 —
University of California San Francisco San Francisco California 94115 —
University of California, San Francisco San Francisco California 94115 —
Dermatology Institute & Skin Care Center Santa Monica California 90404 —
Focus Clinical Research West Hills California 91307 —
Encore Medical Research Boynton Beach Boynton Beach Florida 33436 —
Biobrilliance Medical Research Center Hialeah Florida 33106 —
Encore Medical Research Hollywood Florida 33024 —
Life Arc Research Centers Corp Miami Florida 33126 —
University of Miami Miami Florida 33134 —
Advanced Clinical Research Institute Tampa Florida 33607 —
Encore Medical Research of Weston Weston Florida 33331 —
Emory University Atlanta Georgia 30322 —
Centricity Research Columbus Georgia 31904 —
Treasure Valley Medical Research Boise Idaho 83706 —
MetroMed Clinical Trials Chicago Illinois 60614 —
DS Research of Southern Indiana, LLC Clarksville Indiana 47129 —
Equity Medical Bowling Green Kentucky 42104 —
DS Research of Kentucky, LLC Louisville Kentucky 40241 —
Revival Research Institute, LLC Troy Michigan 48084 —
Medisearch, LLC Saint Joseph Missouri 64506 —
Skin Specialists PC Omaha Nebraska 68144 —
University of New Mexico Department of Dermatology Albuquerque New Mexico 87102 —
Equity Medical New York New York 10023 —
Apex Clinical Research Center - Canton Canton Ohio 44718 —
UC Health Physicians Office Dermatology Cincinnati Ohio 45219 —
Paddington Testing, PO Philadelphia Pennsylvania 01913 —
Columbia Dermatology and Aesthetics Columbia South Carolina 29212 —
International Clinical Research - Tennessee LLC Murfreesboro Tennessee 37130 —
Dermatology Treatment and Research Center Dallas Texas 75230 —
Center for Clinical Studies Webster Texas 77598 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06366750, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 4, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06366750 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →